logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Shunichi Sugawara

Sendai Kousei Hospital

48H指数
414论文数
2.5W被引数
收录论文 91
发表时间
logo
Tarlatamab in small cell lung cancer following platinum-based chemotherapy: subgroup analysis of Japanese patients from the DeLLphi-304 study塔拉他马布在铂类化疗后的小细胞肺癌中的应用：DeLLphi-304研究中日本患者的亚组分析
errInternational Journal of Clinical Oncology
IF2.8
err2026-09-19
err0
errOAAI
errTakayasu Kurata; Shunichi Sugawara; Hiroaki Akamatsu; Kazushige Wakuda; Koichi Azuma; Takayuki Takahama; Hiroshi Kagamu; Hiroshi Yokouchi; Miyako Satouchi; Shuji Murakami; Kadoaki Ohashi; Makoto Nishio; Kazumi Nishino; Hiroki Izumi; Hiroshi Tanaka; Taichi Miyawaki; Shuang Huang; Upen Patil; Jihyun Park; Tatsuya Yoshida
err分享
err收藏
Disease Kinetics and Practice Patterns in ≥4-Year Long-Term Beneficiaries of Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer晚期非小细胞肺癌免疫检查点抑制剂≥4年长期受益者的疾病动力学与实践模式
errJournal of Thoracic Oncology
IF20.8
err2026-07-28
err0
PREAI
errMasahiro Torasawa; Yoshihiro Masui; Keita Miura; Shunichi Kataoka; Masayuki Shirasawa; Yoshiro Nakahara; Junko Baba; Hidenobu Ishii; Maiko Asai; Tomoiki Aiba; Hiroshi Wakui; Shunichi Sugawara; Yukio Hosomi; Hiroshi Tanaka; Katsuhiko Naoki; Kazuhisa Takahashi; Hirotsugu Kenmotsu; Hidehito Horinouchi
err分享
err收藏
Predicting Radiation-Induced Esophagitis in Locally Advanced NSCLC Using Baseline Clinical Factors: A Model from the Japan Lung Cancer Society Integrated Phase II–III Database基于日本肺癌协会整合的II–III期数据库，利用基线临床因素预测局部晚期非小细胞肺癌的放射性食管炎
errClinical Lung Cancer
IF3.3
err2026-04-24
err0
PREAI
errYuji Uehara; Kageaki Watanabe; Jun Tamura; Yuichi Ozawa; Makiko Yomota; Keigo Kishino; Takayuki Kobayashi; Kentaro Taguchi; Keiko Nemoto Murofushi; Satoshi Oizumi; Katsuyuki Hotta; Tsuneo Shimokawa; Seiji Niho; Shunichi Sugawara; Isamu Okamoto; Koji Yamamoto; Nobuyuki Yamamoto; Yukio Hosomi
err分享
err收藏
Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer肿瘤位置对局部晚期非小细胞肺癌同步化放疗疗效的影响
errBritish Journal of Cancer
IF6.8
err2026-04-09
err0
PREAI
errYuichi Ozawa; Kouji Yamamoto; Shunichi Sugawara; Seiji Niho; Hiroaki Okamoto; Katsuyuki Hotta; Isamu Okamoto; Norihiko Ikeda; Nobuyuki Yamamoto
err分享
err收藏
Real-world comparative effectiveness of atezolizumab versus durvalumab for extensive-stage small-cell lung cancer阿替利珠单抗与度伐利尤单抗治疗广泛期小细胞肺癌的实时世界比较有效性
errLung Cancer
IF4.4
err2026-03-02
err0
PREAI
errTomoiki Aiba; Shuichiro Hara; Shinichiro Tominaga; Ryo Yamamoto; Hiroyuki Sakashita; Tadashi Sakaguchi; Yumi Ando; Jun Koshio; Ayako Takigami; Makoto Maemondo; Shunichi Sugawara
err分享
err收藏
Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52Nivolumab联合化疗和贝伐单抗治疗TASUKI-52非鳞NSCLC患者的4年预后
errCancer Science
IF4.3
err2026-01-29
err0
errOAAI
errJong-Seok Lee; Shunichi Sugawara; Jin-Hyoung Kang; Hye Ryun Kim; Naoki Inui; Toyoaki Hida; Ki Hyeong Lee; Tatsuya Yoshida; Hiroshi Tanaka; Cheng-Ta Yang; Takako Inoue; Makoto Nishio; Yasushi Goto; Tomohide Tamura; Nobuyuki Yamamoto; Chong-Jen Yu; Hiroaki Akamatsu; Shigeru Takahashi; Kazuhiko Nakagawa
err分享
err收藏
IMpower010: 5-Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB-IIIA Non-Small Cell Lung Cancer
errCANCER SCIENCE
IF4.3
err2025-12-01
err0
errOAAI
errOkada, Morihito; Sugawara, Shunichi; Watanabe, Yasutaka; Saito, Haruhiro; Chen-yoshikawa, Toyofumi F.; Goto, Yasushi; Nishio, Wataru; Nakagawa, Shizuka; Hayashi, Morihiko; Kenmotsu, Hirotsugu
err分享
err收藏
Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study无放疗的帕博利珠单抗联合化疗治疗PD-L1肿瘤比例评分≥50%的局部晚期非小细胞肺癌（Evolution试验）：一项多中心、单臂、Ⅱ期研究
errThe Lancet Oncology
IF0
err2025-10-11
err0
PREAI
errAkito Hata; Taira Ninomaru; Hideaki Okada; Yoshihito Kogure; Masahide Oki; Nobuyuki Katakami; Takashi Kijima; Toshihide Yokoyama; Hirotaka Matsumoto; Yuki Sato; Terufumi Kato; Shunichi Sugawara; Takeshi Sawada; Kenichi Yoshimura; Takashi Seto; Kazuhiko Nakagawa; Isamu Okamoto; Nobuyuki Yamamoto
err分享
err收藏
Real-world outcomes and association between immune-related adverse events and therapeutic efficacy of nivolumab plus ipilimumab in elderly patients (≥75 years) with advanced non-small cell lung cancer真实世界结局及免疫相关不良事件与纳武利尤单抗联合伊匹木单抗在≥75岁晚期非小细胞肺癌患者中的治疗疗效关联性
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2025-09-30
err0
PREAI
errMinami, Soichiro; Doman, Tsuyoshi; Toi, Yukihiro; Fukuzawa, Keito; Yamazaki, Yusuke; Saito, Shin; Narumi, Akane; Odaka, Tetsuo; Ogasawara, Takahiro; Shimizu, Hisashi; Sugisaka, Jun; Ono, Kana; Aiba, Tomoiki; Kawana, Sachiko; Yamanda, Shinsuke; Kimura, Yuichiro; Sugawara, Shunichi
err分享
err收藏
Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutationsEGFR激活突变阳性的非小细胞肺癌患者在接受EGFR酪氨酸激酶抑制剂治疗期间化疗的生物学影响
errLung Cancer
IF4.4
err2025-09-16
err0
errOAAI
errEiji Iwama; Kazuko Sakai; Taishi Harada; Shintaro Kanda; Shunichi Sugawara; Toshihide Yokoyama; Hirokazu Taniguchi; Kaoru Tanaka; Ryo Toyozawa; Kenichi Koyama; Yoshitaka Zenke; Gen Kida; Yasuhiko Nishioka; Hiroshi Yokouchi; Masayuki Hirose; Kazuto Nishio; Nobuyuki Yamamoto; Yuichiro Ohe; Isamu Okamoto
err分享
err收藏
A case of lower respiratory tract infection caused by Pandoraea sputorum in a human T-lymphotropic virus type 1 carrier一例由Pandoraea sputorum引起的下呼吸道感染，发生在人类T淋巴细胞病毒1型携带者中
errIDCASES
IF0
err2025-09-01
err0
errOAAI
errOgasawara, Takahiro; Yamanda, Shinsuke; Fukuzawa, Keito; Yamazaki, Yusuke; Doman, Tsuyoshi; Minami, Soichiro; Narumi, Akane; Saito, Shin; Odaka, Tetsuo; Ono, Kana; Shimizu, Hisashi; Sugisaka, Jun; Aiba, Tomoiki; Kawana, Sachiko; Toi, Yukihiro; Sugawara, Shunichi; Kimura, Yuichiro
err分享
err收藏
Durvalumab plus irinotecan + cisplatin for untreated extensive-stage small cell lung cancer: REBORN, phase II study (WJOG13520L)度伐利尤单抗联合伊立替康+顺铂用于未经治疗的广泛期小细胞肺癌：REBORN，II期研究（WJOG13520L）
errLung Cancer
IF4.4
err2025-06-29
err0
errOAAI
errMotoko Tachihara; Hiroyasu Shoda; Yuki Akazawa; Takayo Ota; Masahide Oki; Yuki Sato; Shunichi Sugawara; Satoshi Ikeda; Toshihide Yokoyama; Hiroyasu Kaneda; Shoichi Itoh; Akihiro Bessho; Nobuyuki Katakami; Satoshi Morita; Kazuhiko Nakagawa; Isamu Okamoto; Nobuyuki Yamamoto
err分享
err收藏
A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLCDatopotamab Deruxtecan在EGFR突变非小细胞肺癌患者中的合并分析
errJournal of Thoracic Oncology
IF20.8
err2025-06-12
err0
errOAAI
errMyung-Ju Ahn; Aaron Lisberg; Yasushi Goto; Jacob Sands; Min Hee Hong; Luis Paz-Ares; Elvire Pons-Tostivint; Maurice Pérol; Enriqueta Felip; Shunichi Sugawara; Hidetoshi Hayashi; Byoung Chul Cho; George Blumenschein; Elaine Shum; Jong-Seok Lee; Rebecca S. Heist; Robin Cornelissen; Wen-Cheng Chang; Dariusz Kowalski; Hong Zebger-Gong; Michael Chargualaf; Wen Gu; Lan Lan; Paul Howarth; Richard Joseph; Isamu Okamoto
err分享
err收藏
Cardiovascular adverse events in patients with lung cancer treated with immune checkpoint inhibitors: a nationwide database study接受免疫检查点抑制剂治疗的肺癌患者的心血管不良事件：一项全国性数据库研究
errONCOLOGIST
IF4.2
err2025-06-01
err0
errOAAI
errIsawa, Tsuyoshi; Togashi, Shintaro; Taguri, Masataka; Toi, Yukihiro; Sugawara, Shunichi; Toyoda, Shigeru
err分享
err收藏
Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901前瞻性多机构观察性研究：对既往接受过抗PD-1/PD-L1联合化疗治疗的非小细胞肺癌患者进行抗PD-1/PD-L1抗体再治疗的观察研究：NJLCG（北日本肺癌研究组）试验1901
errCANCERS
IF4.4
err2025-05-02
err0
errOAAI
errSaito, Shin; Kawashima, Yosuke; Tanaka, Hisashi; Yoshimura, Naruo; Tsukita, Yoko; Saito, Ryota; Nakagawa, Taku; Inomata, Minehiko; Nagashima, Hiromi; Sugawara, Shunichi
err分享
err收藏
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study30天内出现皮肤疾病是接受尼妥珠单抗联合吉西他滨和顺铂治疗的肺鳞状细胞癌患者的有利预后因素：NINJA研究的亚组分析
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2025-03-15
err0
errOAAI
errFumihiko Kinoshita; Shigeru Tanzawa; Toshihiro Misumi; Hiroshige Yoshioka; Eisaku Miyauchi; Kiichiro Ninomiya; Yasunori Murata; Masafumi Takeshita; Masafumi Yamaguchi; Shunichi Sugawara; Yosuke Kawashima; Kazuki Hashimoto; Masahide Mori; Akihiko Miyanaga; Anna Hayashi; Hisashi Tanaka; Ryoichi Honda; Masafumi Nojiri; Yuki Sato; Ken Yamamoto; Ken Masuda; Toshiyuki Kozuki; Takahisa Kawamura; Takuji Suzuki; Teppei Yamaguchi; Kazuhiro Asada; Satoshi Tetsumoto; Hiroshi Tanaka; Satoshi Watanabe; Yukihiro Umeda; Kakuhiro Yamaguchi; Shoichi Kuyama; Kosuke Tsuruno; Yuki Misumi; Hiroshi Kuraishi; Ken Yoshihara; Akira Nakao; Akihito Kubo; Toshihiko Yokoyama; Kana Watanabe; Nobuhiko Seki
err分享
err收藏
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial一线纳武利尤单抗联合铂类化疗和贝伐珠单抗治疗晚期非鳞非小细胞肺癌：TASUKI-52 III期随机试验3年随访
errLUNG CANCER
IF4.4
err2025-03-01
err0
PREAI
errLee, Ki Hyeong; Lee, Jong-Seok; Sugawara, Shunichi; Kang, Jin Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Ohe, Yuichiro; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru
err分享
err收藏
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studies辅助细胞毒性化疗和吉非替尼在切除肺癌中的纵向复发风险：一项III期研究的联合分析
errLUNG CANCER
IF4.4
err2025-03-01
err0
errOAAI
errAkamatsu, Hiroaki; Nishikawa, Tomomi; Takeda, Yuriko; Misumi, Toshihiro; Aoki, Tadashi; Shoda, Hiroyasu; Yamashita, Motohiro; Sakakura, Noriaki; Daga, Haruko; Sugawara, Shunichi; Okishio, Kyoichi; Kenmotsu, Hirotsugu; Yamamoto, Nobuyuki; Tada, Hirohito; Tsuboi, Masahiro; Mitsudomi, Tetsuya
err分享
err收藏
Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK plus NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trials布加替尼在ALK TKI初治的ALK阳性晚期NSCLC患者中的疗效和安全性：ALTA-1L和J-ALTA试验的整合分析
errLUNG CANCER
IF4.4
err2025-03-01
err0
PREAI
errCamidge, D. Ross; Sugawara, Shunichi; Kondo, Masashi; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Kudou, Kentarou; Asato, Takayuki; Hupf, Bradley; Vranceanu, Florin; Fram, Robert J.; Ohe, Yuichiro; Popat, Sanjay
err分享
err收藏
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study尼妥珠单抗联合顺铂和吉西他滨治疗在晚期肺鳞状细胞癌患者中诱导低镁血症的临床影响：NINJA研究的亚组分析
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2025-02-14
err0
errOAAI
errShigeru Tanzawa; Hiroshige Yoshioka; Toshihiro Misumi; Eisaku Miyauchi; Kiichiro Ninomiya; Yasunori Murata; Masafumi Takeshita; Fumihiko Kinoshita; Takatoshi Fujishita; Shunichi Sugawara; Yosuke Kawashima; Kazuki Hashimoto; Masahide Mori; Akihiko Miyanaga; Anna Hayashi; Hisashi Tanaka; Ryoichi Honda; Masafumi Nojiri; Yuki Sato; Akito Hata; Nobuhisa Ishikawa; Toshiyuki Kozuki; Takahisa Kawamura; Go Saito; Teppei Yamaguchi; Kazuhiro Asada; Satoshi Tetsumoto; Hiroshi Tanaka; Satoshi Watanabe; Yukihiro Umeda; Kakuhiro Yamaguchi; Kazuya Nishii; Kosuke Tsuruno; Yuki Misumi; Hiroshi Kuraishi; Ken Yoshihara; Akira Nakao; Akihito Kubo; Toshihiko Yokoyama; Kana Watanabe; Nobuhiko Seki
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
P
Pasi A. Jänne
H 指数: 163 · 论文数: 2.3K
J
James Chih‐Hsin Yang
H 指数: 141 · 论文数: 1.2K
T
Tony Mok
H 指数: 131 · 论文数: 1.1K
E
Enriqueta Felip
H 指数: 129 · 论文数: 1.5K
J
John V. Heymach
H 指数: 128 · 论文数: 2.4K
查看更多